This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Connective and other soft tissue of thorax
CD2_BENIGN_CONNSOFT_THX_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D21
- Name in latin
- Neoplasma benignum textus connectivi/textus mollis thoracis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Connective and other soft tissue of thorax
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Connective and other soft tissue of thorax
- Other benign neoplasms of connective and other soft tissue
- Other benign neoplasms of connective and other soft tissue
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 155 | 84 | 71 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | 53.37 | 47.89 | 59.85 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 136
- Matched controls
- 1360
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D21.3
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of thorax
+∞
169.6
125
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
21.5
25.6
38
24
H02AB02
ATC
dexamethasone; systemic
103.0
17.0
18
*
130
Kela drug reimbursment
Malignant tumour
+∞
12.7
12
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
10.5
10
*
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
13.7
10.2
17
14
JN4BD
NOMESCO Finland
Extensive body CT
8.8
9.5
20
26
L03AA02
ATC
filgrastim; parenteral
+∞
9.5
9
*
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
17.1
9.3
14
9
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
8.4
8
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
8.4
8
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
8.4
8
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
8.4
8
*
GA1CG
NOMESCO Finland
Extensive MRI of chest
+∞
8.4
8
*
D17.1
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
12.9
7.8
13
11
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
7.4
7
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
7.4
7
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
7.4
7
*
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
21.4
7.2
10
5
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
14.8
7.0
11
8
A04AA01
ATC
ondansetron; systemic, rectal
11.8
6.9
12
11
TQW99
NOMESCO Finland
Other minor procedure on skin
10.8
6.7
12
12
C61
ICD-10 Finland
Malignant neoplasm of prostate
73.1
6.5
7
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
73.1
6.5
7
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
6.3
6
*
GAE06
NOMESCO Finland
Excision of lesion of chest wall
+∞
6.3
6
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
6.3
6
*
L01BC06
ATC
capecitabine; oral
+∞
6.3
6
*
115
Kela drug reimbursment
Breast cancer
+∞
6.3
6
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
90
529
2.67
8.23
7.3
4.7
1.2
1.2
mmol/l
0.39
76
458
81
476
2.47
7.09
5.2
4.4
1.2
1.2
mmol/l
0.41
76
429
36
151
2.80
6.21
1.8
1.8
—
—
—
0
0
74
442
2.29
5.97
2.4
2.3
78.1
76.3
nmol/l
0.22
67
397
100
686
2.29
5.67
4.1
3.8
6.7
6.7
mmol/l
0.04
95
629
77
490
2.14
5.09
4.2
3.3
—
—
—
0
0
64
395
2.06
4.45
3.1
2.7
—
—
—
0
0
55
325
2.07
4.27
2.6
2.7
0.1
0.5
e6/l
1.50
39
228
17
58
3.17
4.16
1.8
3.2
2.7
2.3
mmol/l
—
10
44
84
583
1.96
4.10
8.3
3.4
16.6
11.5
umol/l
0.53
79
543
12
33
3.86
4.01
2.4
1.8
—
—
—
0
0
39
209
2.16
3.86
1.9
1.8
1002.9
1169.0
nmol/l
0.59
27
165
58
361
1.97
3.84
2.2
2.0
62.3
58.8
u/l
0.20
53
332
89
640
1.92
3.81
11.2
6.1
3.9
4.2
e9/l
0.75
78
546
136
1148
2.51
3.61
16.4
9.9
82.4
80.9
ml/min/173m2
0.31
117
917
115
917
1.98
3.44
4.7
3.9
11.5
10.8
mm/h
0.23
103
846
39
220
2.03
3.35
2.6
1.7
—
—
—
0
0
145
1275
3.13
3.30
20.3
12.7
4.0
4.0
mmol/l
0.22
140
1232
6
7
8.85
3.29
1.0
1.1
338.7
266.1
u/l
—
6
7
18
74
2.62
3.18
2.9
1.9
0.2
0.2
g/l
0.17
18
65
54
350
1.83
3.05
3.0
3.0
1747.1
1073.5
ng/l
0.44
48
293
5
5
10.27
3.00
1.0
1.0
7.6
9.8
u/l
—
5
5
5
6
8.56
2.77
1.2
1.2
319.2
241.7
mg/l
—
5
6
47
300
1.81
2.76
3.1
2.3
314.5
4656.5
umol/l
1.05
37
262
41
255
1.83
2.60
2.5
1.9
2.5
2.9
mg/l
1.14
36
216
6
11
5.62
2.57
1.8
1.1
—
—
—
0
0
6
12
5.15
2.42
1.8
1.1
—
—
—
0
0
37
228
1.82
2.41
4.7
3.4
133.3
101.2
ng/l
0.16
29
171
112
939
1.69
2.24
4.4
3.7
14.8
14.7
pmol/l
0.33
102
858
8
24
3.46
2.21
1.4
1.3
—
—
—
0
0
8
24
3.46
2.21
1.6
2.0
—
—
—
0
0
5
10
5.12
2.08
1.2
1.2
—
—
—
0
0
21
112
2.01
2.08
1.6
1.8
—
—
—
0
0
9
32
2.92
2.03
2.7
1.7
—
—
—
0
0
27
159
1.85
2.02
19.9
22.1
1.4
1.3
inr
—
5
24
74
571
1.57
2.01
3.8
3.2
0.0
0.0
estimate
0.00
18
102
144
1318
2.30
1.97
21.5
12.4
77.9
77.6
umol/l
0.04
144
1318
138
1244
2.00
1.97
19.1
10.8
20.4
21.3
mg/l
0.14
120
936
74
574
1.55
1.95
4.7
4.6
0.0
0.0
estimate
0.00
18
101
44
303
1.63
1.91
4.0
3.3
0.0
0.0
estimate
0.00
17
98
40
270
1.65
1.87
1.8
1.6
1.1
1.1
mg/l
0.02
34
208
5
12
4.27
1.83
2.0
1.1
—
—
—
0
0
5
12
4.27
1.83
2.0
1.1
—
—
—
0
0
5
12
4.27
1.83
2.0
1.1
—
—
—
0
0
5
12
4.27
1.83
2.0
1.1
—
—
—
0
0
74
581
1.52
1.81
3.8
3.3
0.0
0.0
estimate
0.00
17
98
12
54
2.32
1.79
1.7
1.8
—
—
—
0
0
6
18
3.42
1.76
1.2
1.2
—
—
—
0
0
15
76
2.08
1.71
2.5
3.1
1.2
1.2
mmol/l
0.19
15
63
38
261
1.60
1.65
1.4
1.2
0.8
2.5
u/ml
—
9
75
28
178
1.70
1.63
3.1
2.6
0.9
2.6
e6/l
1.17
13
87
5
14
3.65
1.63
1.2
1.0
—
—
—
0
0
58
441
1.50
1.61
3.8
3.2
—
—
—
0
0
65
508
1.48
1.57
2.7
2.6
107.0
107.2
ug/l
0.00
60
477
30
198
1.64
1.52
2.5
2.4
0.4
1.2
e6/l
2.55
15
107
23
141
1.74
1.52
4.9
4.1
28.0
31.2
%
0.64
17
94
6
21
2.93
1.52
2.0
1.1
—
—
—
0
0
17
95
1.89
1.50
3.7
3.3
—
—
—
0
0
35
242
1.58
1.48
1.8
1.7
428.5
435.7
pmol/l
0.07
30
206
21
128
1.74
1.42
8.3
7.3
—
—
—
0
0
19
113
1.78
1.39
1.6
1.7
—
—
—
0
0
32
221
1.56
1.36
1.6
1.6
—
—
—
0
0
6
24
2.56
1.31
1.0
1.1
—
—
—
0
0
8
35
2.35
1.29
1.4
1.2
27.1
20.3
iu/l
—
8
29
59
478
1.38
1.10
4.5
3.5
38.5
45.7
ng/l
0.11
37
327
126
1156
1.48
1.09
5.7
4.3
11.5
1.9
mu/l
0.51
117
1057
15
90
1.74
1.08
3.7
1.9
79.2
65.9
ml/min/173m2
—
6
32
5
22
2.31
1.04
2.0
1.3
—
—
—
0
0
9
48
1.93
1.02
6.3
5.8
24.3
25.1
mmol/l
—
9
43
7
35
2.05
1.01
1.4
1.2
—
—
—
0
0
19
125
1.59
0.99
5.5
5.1
1.1
1.4
mmol/l
0.13
14
99
9
50
1.85
0.98
1.6
1.2
—
—
—
0
0
59
486
1.35
0.98
2.3
1.8
90.1
96.2
pmol/l
0.51
25
239
32
239
1.43
0.94
3.1
2.5
0.6
0.7
ug/l
0.39
19
161
6
27
2.27
0.94
2.2
2.9
23.7
25.6
mmol/l
—
6
20
6
28
2.19
0.92
6.0
1.9
4839.3
12.1
u/ml
—
6
22
18
121
1.55
0.87
5.8
5.3
5.2
5.1
kpa
0.14
18
113
18
121
1.55
0.87
5.8
5.3
13.5
11.5
kpa
0.81
18
114
6
32
1.91
0.82
1.2
1.1
—
—
—
0
0
6
34
1.79
0.77
1.8
2.7
—
—
—
0
0
5
24
2.12
0.75
1.0
1.0
—
—
—
0
0
10
60
1.71
0.74
1.0
1.0
—
—
—
0
0
7
39
1.83
0.73
4.3
1.4
—
—
—
0
0
5
28
1.81
0.66
2.0
1.3
48.2
336.5
e6/l
—
5
20
5
29
1.75
0.64
1.6
1.4
—
—
—
0
0
0
21
0.00
0.60
0.0
1.3
—
57.0
—
0
21
12
81
1.52
0.59
1.1
1.2
127.3
128.9
iu/ml
—
5
31
132
1262
1.31
0.53
5.4
4.9
2.8
2.7
mmol/l
0.41
125
1173
16
118
1.40
0.52
1.7
1.8
—
—
—
0
0
125
1188
1.27
0.52
4.5
3.9
1.3
1.3
mmol/l
0.37
118
1088
122
1158
1.25
0.50
6.5
5.7
40.3
39.7
mmol/mol
0.34
111
1087
128
1222
1.27
0.49
4.8
4.3
6.0
5.9
mmol/l
0.29
117
1128
10
68
1.50
0.48
1.9
1.3
—
—
—
0
0
9
126
0.70
0.45
1.6
1.8
—
—
—
0
0
48
421
1.20
0.45
5.0
3.5
3.1
1.9
ug/l
0.47
39
381
128
1227
1.25
0.43
4.9
4.3
1.5
1.5
mmol/l
0.14
120
1137
16
123
1.34
0.42
1.8
2.5
5.2
7.9
umol/l
0.50
16
106
0
16
0.00
0.41
0.0
1.4
—
2.4
—
0
5
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
9
67
1.36
0.39
1.4
1.3
—
—
—
0
0
10
135
0.72
0.38
1.4
2.0
—
—
—
0
0
128
1235
1.21
0.35
4.8
4.4
4.7
4.6
mmol/l
0.24
120
1155
5
71
0.69
0.26
1.0
2.0
—
—
—
0
0
37
334
1.14
0.24
4.9
3.3
17.3
24.5
%
1.79
16
151
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
0
13
0.00
0.21
0.0
2.6
—
13.8
—
0
13
6
50
1.21
0.20
1.7
1.5
—
—
—
0
0
21
188
1.14
0.15
1.5
1.4
—
—
—
0
0
82
794
1.07
0.12
3.1
3.2
—
—
—
0
0
5
60
0.83
0.08
1.4
1.3
—
—
—
0
0
117
1164
1.02
0.00
17.1
11.8
39.8
40.5
%
0.39
90
866
22
221
0.99
0.00
1.3
1.2
1.7
5.8
u/ml
—
7
80
6
61
0.98
0.00
1.5
2.9
25.8
24.9
mmol/l
—
6
56
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_CONNSOFT_THX_EXALLC – Benign neoplasm: Connective and other soft tissue of thorax
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).